関連する実験動画
Updated: Jan 21, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
1.4K
潰瘍性大腸炎におけるヒトの大腸の細胞内および細胞間再配線
Christopher S Smillie1, Moshe Biton2, Jose Ordovas-Montanes3
1Klarman Cell Observatory, Broad Institute, Cambridge, MA, USA.
Cell
|July 27, 2019
まとめ
この研究は,潰瘍性大腸炎 (UC) リスク遺伝子を,大腸の特定の細胞タイプにマッピングします. 新しい細胞サブセットとUCの病原化と抗TNF治療への抵抗に関与する経路を特定します.
科学分野:
- 胃腸内科
- 免疫学
- 遺伝学
背景:
- 全ゲノム関連研究 (GWAS) では,潰瘍性大腸炎 (UC) の多くのリスクアレルが特定されています.
- UCの病原化に伴う細胞および分子メカニズムは,まだ完全に理解されていません.
- 細胞型特異的なUCリスク遺伝子の機能はほとんど不明である.
研究 の 目的:
- 単細胞のアトラスを作成する.
- UCリスクアレルに関連した細胞タイプと経路を特定する.
- UCにおける抗TNF治療に対する耐性のメカニズムの調査.
主な方法:
- 単細胞RNA配列解析 (scRNA-seq) は,UC患者および健康な対照群の結腸粘膜から36万650個の細胞を採取した.
- 異なる細胞サブセットと遺伝子発現パターンを特定するためのバイオ情報分析.
- scRNA-seqデータとGWASの発見を統合し,リスク変異をマッピングする.
主要な成果:
- 新型BEST4+腸細胞,マイクロフォールド型の細胞,およびIL13RA2+IL11+炎症性線維芽細胞を含む51の表皮細胞,構造細胞および免疫細胞サブセットの特定.
- 特定の細胞タイプ (炎症性線維芽細胞,単細胞,T細胞) と疾患拡大および細胞間通信ハブとの関連.
- 多くのUCリスク遺伝子を特定の細胞タイプと共同調節された遺伝子モジュールにマッピングし,経路の収束を示唆しています.
- 炎症性フィブロブラストの特定は,抗TNF治療への抵抗と関連している可能性がある.
結論:
- 潰瘍性大腸炎の病原化には,特定の細胞タイプと経路が関与し,リスク遺伝子の効果が収束します.
- 生成された細胞アトラスは,UCの遺伝的リスクと疾患メカニズムを理解するための枠組みを提供します.
- 新しい細胞のサブセットとその機能は,UCにおける治療的介入のための新しいターゲットを提供します.
さらに関連する動画
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
32.5K
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
10.5K
関連する概念動画
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
926
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
926
01:29Drugs for Treatment of Ulcerative Colitis in IBD
468
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
468
02:22The Colonization of Land
37.4K
Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.4K
01:28Peptic Ulcer Disease II: Pathophysiology
2.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
01:30Peptic Ulcer Disease I: Introduction
757
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
757
01:26Peptic Ulcer Disease IV: Management
448
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
448